RGH 790

Drug Profile

RGH 790

Alternative Names: RGH-790

Latest Information Update: 14 Apr 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Gedeon Richter
  • Class Antipsychotics
  • Mechanism of Action Dopamine D2 receptor agonists; Dopamine D3 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Psychotic disorders

Most Recent Events

  • 14 Apr 2016 Discontinued - Phase-I for Psychotic disorders (In volunteers) in Hungary (PO)
  • 07 Nov 2012 Discontinued - Phase-I for Psychotic disorders in United Kingdom (PO)
  • 17 Oct 2012 Pharmacokinetics & adverse events data from a phase I trial in healthy volunteers presented at the 25th Annual Congress of the European College of Neuropsychopharmacology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top